Brazil
Canada
Germany
Japan
Archived Events
Archived Events
-
Aug 3, 2022 at 8:00 AM EDT Horizon Therapeutics Second Quarter 2022 Earnings Call
Supporting Materials
Q2 2022 Earnings Release 513.5 KBQ2 2022 Presentation 3.3 MBQ2 2022 Conference Call Remarks 286.3 KB -
Jun 14, 2022 at 11:00 AM EDT Goldman Sachs 43rd Annual Global Health Care Conference
-
May 4, 2022 at 8:00 AM EDT Horizon Therapeutics First Quarter 2022 Earnings Call
Supporting Materials
Q1 2022 Earnings Release 484.1 KBQ1 2022 Presentation 2.6 MBQ1 2022 Conference Call Remarks 254.5 KB -
Mar 8, 2022 at 11:10 AM EST Cowen and Company 42nd Annual Health Care Conference
-
Mar 1, 2022 at 8:00 AM EST Horizon Therapeutics Fourth Quarter 2021 Earnings Call
Supporting Materials
Q4 2021 Earnings Release 433.3 KBQ4 2021 Presentation 2.5 MBQ4 2021 Conference Call Remarks 187.5 KB -
Jan 10, 2022 at 11:15 AM EST 40th Annual J.P. Morgan Healthcare Conference
-
Jan 6, 2022 at 9:00 AM EST Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
-
Nov 30, 2021 at 9:00 AM EST Piper Sandler 33rd Annual Health Care Conference (Virtual)
-
Nov 16, 2021 at 2:00 PM EST Stifel 2021 Health Care Conference (Virtual)
-
Nov 15, 2021 at 9:00 AM EST Guggenheim 3rd Annual Neuro/Immunology Conference (Virtual)
-
Nov 3, 2021 at 8:00 AM EDT Horizon Therapeutics Third Quarter 2021 Earnings Call
Supporting Materials
Q3 2021 Earnings Release 396.1 KBQ3 2021 Presentation 3 MBQ3 2021 Conference Call Remarks 243.5 KB -
Sep 29, 2021 at 9:00 AM EDT Virtual R&D Day for Investors and Analysts
Supporting Materials
R&D Day Remarks 389.1 KB9.29.21 Press Release 249.4 KB6.30.21 Press Release 20.5 KB -
Feb 1, 2021 at 8:00 AM EST Horizon Viela Bio Acquisition Conference Call
Supporting Materials
-
Jul 31, 2020 at 9:00 AM EDT New TEPEZZA OPTIC-X and OPTIC Trial Data
-
Jun 23, 2020 at 10:30 AM EDT BMO 2020 Prescriptions for Success Healthcare Conference (Virtual)
-
Jun 4, 2020 at 3:00 PM EDT KRYSTEXXA Immunomodulation Strategy and EULAR Data
Supporting Materials
-
Apr 2, 2020 at 8:00 AM EDT Horizon Acquisition of Curzion (4/2/20)
-
Apr 29, 2019 Dr. R. Douglas’s AACE IR TED/OPTIC Presentation
-
Feb 28, 2019 at 8:00 AM EST Overview of Teprotumumab OPTIC Phase 3 Trial Topline Results and Thyroid Eye Disease (TED)
Supporting Materials
-
Oct 4, 2018 at 10:30 AM EDT Overview of Thyroid Eye Disease (TED) and Teprotumumab Clinical Data
Supporting Materials
-
Nov 9, 2017 at 10:00 AM EST KRYSTEXXA ACR Investor Webcast & Presentation
Supporting Materials